RPL41, a small ribosomal peptide deregulated in tumors, is essential for mitosis and centrosome integrity

Shan Wang1, Jianmin Huang, Jie He

  • 1Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA.

Neoplasia (New York, N.Y.)
|March 18, 2010
PubMed

Insights

Ribosomal large subunit protein 41 (RPL41) acts as a tumor suppressor. Its down-regulation promotes malignant transformation by disrupting microtubule stability, centrosome integrity, and proper cell division.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Ribosomal large subunit protein 41 (RPL41) is a small, basic peptide.
  • The function of RPL41 in cellular processes, particularly in cancer, remains largely unexplored.

Purpose of the Study:

  • To investigate the role of RPL41 in cellular transformation and tumor suppression.
  • To elucidate the molecular mechanisms underlying RPL41's function, focusing on its interaction with the cytoskeleton.

Main Methods:

  • Antisense-based screening and small interfering RNA (siRNA) for RPL41 depletion in NIH3T3 cells.
  • Fluorescence in situ hybridization (FISH) and real-time quantitative reverse transcription-polymerase chain reaction (RT-qPCR) to assess RPL41 levels in cell lines and primary tumors.
  • Mass spectrometry and Western blot analysis to identify RPL41 interacting proteins.
  • Functional assays including soft agar colony formation, tumor growth in mice, microtubule depolymerization resistance, cell cycle analysis, and centrosome integrity assessment.

Main Results:

  • RPL41 depletion induced anchorage-independent growth and malignant transformation of NIH3T3 cells, leading to increased tumor growth in mice.
  • RPL41 deletion/down-regulation was frequent in tumor cell lines (59%) and primary breast cancers (75%), suggesting a tumor suppressor role.
  • RPL41 was identified as a microtubule-associated protein, directly binding to polymerized tubulins and stabilizing microtubules.
  • RPL41 depletion caused abnormal mitosis, cytokinesis failure, polynuclear cells, and premature centrosome splitting, indicating disrupted spindle function and centrosome integrity.

Conclusions:

  • RPL41 functions as a tumor suppressor by maintaining microtubule stability and centrosome integrity.
  • Disruption of RPL41 leads to aberrant mitosis and centrosome dysfunction, contributing to malignant transformation.
  • RPL41 represents a potential therapeutic target in cancers characterized by its down-regulation.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Riboswitches01:56

Riboswitches

Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...